Imupret N

Imupret N, the active ingredient in Imupret N, is a herbal medicinal product presented as a tablet for oral use. It is intended to relieve symptoms of acute pharyngitis, tonsillitis, sore throat and other upper respiratory tract infections in adults and children.

GNH USA supplies Imupret N as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Imupret N is used in the management of inflammatory conditions of the upper respiratory tract. - Acute pharyngitis: helps reduce throat inflammation and discomfort. - Tonsillitis: supports relief of swelling and pain in the tonsils. - Sore throat: provides soothing action to ease irritation. - Upper respiratory tract infections: contributes to overall symptom mitigation.

Imupret N is generally well tolerated, but some users may experience adverse reactions.

Common Side Effects: - Mild gastrointestinal upset: occasional nausea or stomach discomfort. - Altered taste: temporary metallic or bitter sensation. - Skin rash: mild erythema or itching at the site of contact. - Headache: transient mild headache.

Serious or Rare Side Effects: - Anaphylactic reaction: severe allergy requiring immediate medical attention. - Hepatic enzyme elevation: rare liver function changes. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Persistent dizziness: uncommon but noteworthy.

Before using Imupret N, consider the following safety measures. - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use with caution and seek medical advice. - Known hypersensitivity: avoid if allergic to any listed plant ingredients. - Anticoagulant therapy: monitor for increased bleeding tendency. - Children under six years: not recommended without medical supervision. - Store at ambient temperature: keep in the original pack, protect from moisture.

Imupret N may interact with other medicines or supplements.

Major Interactions (Avoid): - Concurrent immunosuppressants: may diminish therapeutic effect. - Anticoagulant drugs (e.g., warfarin): increased risk of bleeding.

Moderate Interactions (Monitor Closely): - Other anti‑inflammatory herbs: additive anti‑inflammatory effect. - Antibiotics: possible synergistic antimicrobial activity. - MAO inhibitors: theoretical risk of hypertensive response. - Herbal supplements containing similar botanicals: monitor for cumulative exposure.